BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

XYREM Pages on BioPortfolio:

Biotechnology News XYREM Search
PR inside: Nov 13 2009 5:22PM Matching: xyrem, Find similar documents ... Jazz Pharma 3Q loss narrows on Xyrem sales 49 mins ago ...
http://www.bioportfolio.co.uk/XYREM-news.htm...

BioPortfolio - Xyrem
1Q09 Xyrem(R) net sales of $18 million are 56% higher than 1Q08 - 1Q09 operating expenses of $29 million are 50% lower than 1Q08 PALO ALTO, Calif., ...
http://www.bioportfolio.com/indepth/Xyrem.html...

BioPortfolio's Mycoplasma News and Headlines
New European Approval for Xyrem Provides Significant Advance in the Treatment of ... UCB and Jazz Pharmaceuticals expand Xyrem license agreement to include ...
http://www.bioportfolio.co.uk/Health_News/Narcolepsy.shtml...

BioPortfolio - Orphan Medical Incorporated - Profile
From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of .... Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With ...
http://www.bioportfolio.com/biocorporate/7917-Orphan%2525252...

BioPortfolio's Excessive Daytime Sleepiness News and Headlines
Xyrem(R) (Sodium Oxybate) Receives FDA Approval for the Treatment of Excessive ... Orphan Medical Submits Xyrem sNDA to Include Improvement in Other Primary
...
http://www.bioportfolio.co.uk/Health_News/Excessive_Daytime_...

Stakeholder Opinions: Narcolepsy - Entry-point to a lucrative ...
18 Dec 2008 ... *Analysis of narcolepsy market IMS sales data from 2004 to 2007 for major marketed narcolepsy drugs: Provigil and Xyrem. ...
http://www.bioportfolio.com/cgi-bin/acatalog/Stakeholder_Opi...

BioPortfolio Limited Stakeholder Opinions: Narcolepsy - Entry ...
Provigil and Xyrem are first-line treatment options for narcolepsy 34 ... Summary of Xyrem's clinical trial data in narcolepsy 66. Future outlook 68 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_148.html...

BioPortfolio News: Jazz Pharmaceuticals, Inc. - Jazz ...
XYREM® (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, ...
http://www.bioportfolio.com/news/Jazz-Pharmaceuticals-Announ...

BioPortfolio - Orphan Medical Incorporated
Orphan Medical Incorporated Clinical Trials: Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients ...
http://www.bioportfolio.com/biocorporate/7917-Orphan_Medical...

BioPortfolio - Jazz Pharmaceuticals, Inc. - Jazz Pharmaceuticals ...
5 Nov 2009 ... Pharmaceuticals' ability to increase sales of XYREM and LUVOX CR; Jazz Pharmaceuticals' dependence on single source suppliers and ...
http://www.bioportfolio.com/news/Jazz-Pharmaceuticals-Announ...

Results from other life science and pharmaceutical sites:

Xyrem - Wikipedia, the free encyclopedia
This article describes the status of Xyrem as a prescription drug. To learn about the chemical and its biological mode of action, see the article on ...
http://en.wikipedia.org/wiki/Xyrem...

Xyrem Price Increase - Discussion - Sleep disorders support group ...
My wife has narcolepsy and has been on Xyrem for about 18 months. When we reordered prescription last week Express-Scripts advised there has ...
http://www.inspire.com/groups/sleep-disorders/discussion/xyr...

From Club Drug to Orphan Drug: Xyrem Risk Management Program
Xyrem Risk Management Program: n July 17, 2002, the Food and Drug Administration (FDA) approved sodium oxybate (Xyrem; Orphan Medical, Inc., Minnetonka, ...
http://www.medscape.com/viewarticle/461409_8...

The Xyrem risk management program.
The Xyrem risk management program. Fuller DE, Hornfeldt CS, Kelloway JS, Stahl PJ, Anderson TF. Orphan Medical Inc., Minnetonka, Minnesota 55305, USA. ...
http://www.ncbi.nlm.nih.gov/pubmed/15061684...

Cataplexy Agents - Xyrem - Pharmacy Clinical Policy Bulletins ...
Under some plans, including plans that use an open or closed formulary, Xyrem is subject to precertification. If precertification requirements apply Aetna ...
http://www.aetna.com/products/rxnonmedicare/data/2009/CNS200...

FDA Approvals: Effexor XR, Xyrem, Antara
28 Nov 2005 ... The FDA has approved new indications for extended-release venlafaxine HCl capsules (Effexor XR) and sodium oxybate oral solution (Xyrem), ...
http://www.medscape.com/viewarticle/518007...

Jazz Pharma 3Q loss narrows on Xyrem sales - Yahoo! Finance
6 Nov 2009 ... PALO ALTO, Calif. (AP) -- Jazz Pharmaceuticals Inc. said late Thursday its third -quarter loss narrowed as sales of the sleep disorder ...
http://biz.yahoo.com/ap/091106/us_earns_jazz_pharmaceuticals...

International Approvals: Symbicort SMART, Alimta, Xyrem
19 Mar 2007 ... Canada has approved budesonide plus formoterol fumarate dehydrate inhalation aerosol (Symbicort SMART) and a new indication for indication ...
http://www.medscape.com/viewarticle/553804...

Three deaths associated with use of Xyrem.
We report three deaths associated with use of Xyrem (sodium oxybate), a pharmaceutical preparation of GHB initially approved for treatment of narcolepsy
...
http://www.ncbi.nlm.nih.gov/pubmed/19269893...

NDA 21-196/S-005 Page 1 FDA Approved Labeling Text dated 11/18/05 ...
use of Xyrem. If you have any questions about Xyrem, ask your doctor or call the ... What is the most important information I should know about Xyrem? ...
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089830.pdf...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.